Cargando…
JAK Inhibitors as Potential Therapeutic Strategy for the Dilemma of Psoriasis Concurrent with Dermatomyositis in the SARS-CoV-2 Era
Dermatomyositis is a rare inflammatory disease with potentially life-threatening systemic involvement that is treated with systemic corticosteroids. However, when psoriasis coexists with dermatomyositis, the administration of corticosteroids may exacerbate psoriasis after withdrawal, posing a treatm...
Autores principales: | Xu, Qiannan, Xu, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124744/ https://www.ncbi.nlm.nih.gov/pubmed/37102163 http://dx.doi.org/10.2147/CCID.S403970 |
Ejemplares similares
-
Pharmacophore and Virtual Screening of JAK3 inhibitors
por: Rajeswari, Murugesan, et al.
Publicado: (2014) -
SARS-CoV-2 and viral sepsis: observations and hypotheses
por: Li, Hui, et al.
Publicado: (2020) -
Use of Hydrogen as a Novel Therapeutic Strategy Against Photoreceptor Degeneration in Retinitis Pigmentosa Patients
por: Tao, Ye, et al.
Publicado: (2016) -
A Novel Hypothesis on Excessive Activation of Residual B Lymphocytes in Common Variable Immunodeficiency Concurrent with Aseptic, Erosive Polyarthritis
por: Mo, Ying-Qian, et al.
Publicado: (2018) -
A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior
por: Zhang, Chuanfu, et al.
Publicado: (2010)